Syndax Pharmaceuticals (SNDX) PT Lowered to $37 at UBS
Get Alerts SNDX Hot Sheet
Price: $19.29 -1.28%
Rating Summary:
18 Buy, 2 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 14 | Down: 11 | New: 36
Rating Summary:
18 Buy, 2 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 14 | Down: 11 | New: 36
Join SI Premium – FREE
UBS analyst David Dai lowered the price target on Syndax Pharmaceuticals (NASDAQ: SNDX) to $37.00 (from $38.00) while maintaining a Buy rating.
You May Also Be Interested In
- Morgan Stanley Upgrades DNB ASA (DNB:NO) (DNHBY) to Equalweight
- Citi Downgrades LexinFintech Holdings (ADR) (LX) to Neutral
- CTP NV (CTPNV:NA) PT Lowered to EUR17 at Morgan Stanley
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share